In the present review, we focus on the involvement of the transmembrane protein tyrosine phosphatase receptor zeta 1 (PTPRZ1) in cancer growth and angiogenesis and discuss its potential as a drug target or as a biomarker, depending on the tumor type. This evidence concerns the gene PTPRZ1 and neoplasm.